The Longevity-Associated BPIFB4 Variant is Anti-Inflammatory
Research suggests that a variant in the BPIFB4 gene is linked to longevity in humans due to its anti-inflammatory properties. Chronic inflammation is a key factor in age-related diseases, but individuals with the Longevity-Associated Variant (LAV) of BPIFB4 show reduced inflammation and improved cardiovascular health. By analyzing proteins in the blood, researchers have identified differences between LAV-BPIFB4 carriers and others, providing insights for better disease management. Learn more about this breakthrough here.
